Artigos de revistas sobre o tema "Clot structure"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 50 melhores artigos de revistas para estudos sobre o assunto "Clot structure".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.
Smith, Stephanie A., e James H. Morrissey. "Polyphosphate Enhances Fibrin Clot Structure." Blood 110, n.º 11 (16 de novembro de 2007): 403. http://dx.doi.org/10.1182/blood.v110.11.403.403.
Texto completo da fonteMihalko, Emily, e Ashley C. Brown. "Clot Structure and Implications for Bleeding and Thrombosis". Seminars in Thrombosis and Hemostasis 46, n.º 01 (15 de outubro de 2019): 096–104. http://dx.doi.org/10.1055/s-0039-1696944.
Texto completo da fonteWolberg, Alisa S., Dougald M. Monroe, Harold R. Roberts e Maureane Hoffman. "Elevated prothrombin results in clots with an altered fiber structure: a possible mechanism of the increased thrombotic risk". Blood 101, n.º 8 (15 de abril de 2003): 3008–13. http://dx.doi.org/10.1182/blood-2002-08-2527.
Texto completo da fonteSmith, Stephanie A., e James H. Morrissey. "Polyphosphate enhances fibrin clot structure". Blood 112, n.º 7 (1 de outubro de 2008): 2810–16. http://dx.doi.org/10.1182/blood-2008-03-145755.
Texto completo da fonteCelińska-Löwenhoff, Magdalena, Teresa Iwaniec, Agnieszka Padjas, Jacek Musiał e Anetta Undas. "Altered fibrin clot structure/function in patients with antiphospholipid syndrome: association with thrombotic manifestation". Thrombosis and Haemostasis 112, n.º 08 (2014): 287–96. http://dx.doi.org/10.1160/th13-11-0980.
Texto completo da fonteCarr, M. E., e S. L. Zekert. "Abnormal clot retraction, altered fibrin structure, and normal platelet function in multiple myeloma". American Journal of Physiology-Heart and Circulatory Physiology 266, n.º 3 (1 de março de 1994): H1195—H1201. http://dx.doi.org/10.1152/ajpheart.1994.266.3.h1195.
Texto completo da fonteGersh, Kathryn, Chandrasekaran Nagaswami e John Weisel. "Fibrin network structure and clot mechanical properties are altered by incorporation of erythrocytes". Thrombosis and Haemostasis 102, n.º 12 (2009): 1169–75. http://dx.doi.org/10.1160/th09-03-0199.
Texto completo da fonteHenderson, Sara J., Jing Xia, Huayin Wu, Alan R. Stafford, Beverly A. Leslie, James C. Fredenburgh, David A. Weitz e Jeffrey I. Weitz. "Zinc promotes clot stability by accelerating clot formation and modifying fibrin structure". Thrombosis and Haemostasis 115, n.º 03 (2016): 533–42. http://dx.doi.org/10.1160/th15-06-0462.
Texto completo da fonteMartinez, Marissa R., Adam Cuker, Angela M. Mills, Amanda Crichlow, Richard T. Lightfoot, Irina N. Chernysh, Chandrasekaran Nagaswami, John W. Weisel e Harry Ischiropoulos. "Enhanced lysis and accelerated establishment of viscoelastic properties of fibrin clots are associated with pulmonary embolism". American Journal of Physiology-Lung Cellular and Molecular Physiology 306, n.º 5 (1 de março de 2014): L397—L404. http://dx.doi.org/10.1152/ajplung.00265.2013.
Texto completo da fonteJanmey, PA, JA Lamb, RM Ezzell, S. Hvidt e SE Lind. "Effects of actin filaments on fibrin clot structure and lysis". Blood 80, n.º 4 (15 de agosto de 1992): 928–36. http://dx.doi.org/10.1182/blood.v80.4.928.928.
Texto completo da fonteJanmey, PA, JA Lamb, RM Ezzell, S. Hvidt e SE Lind. "Effects of actin filaments on fibrin clot structure and lysis". Blood 80, n.º 4 (15 de agosto de 1992): 928–36. http://dx.doi.org/10.1182/blood.v80.4.928.bloodjournal804928.
Texto completo da fonteVarin, Remi, Shasultan Mirshahi, Pehzman Mirshahi, Li Lu-Hong, Gerald Kierzek, Jean-Francois Vigneau, Jean-Pierre Marie et al. "Improvement of Thrombolysis by Rivaroxaban, An Anti Xa Inhibitor. Potential Therapeutic Importance in Patients with Thrombosis". Blood 112, n.º 11 (16 de novembro de 2008): 3031. http://dx.doi.org/10.1182/blood.v112.11.3031.3031.
Texto completo da fonteFaes, Camille, Anton Ilich, Erica M. Sparkenbaugh, Alisa S. Wolberg, Brian C. Cooley, Kenneth I. Ataga, Nigel S. Key e Rafal Pawlinski. "Alteration of the Structure and Dynamics of Venous Clot Formation in Human and Murine Sickle Cell Disease". Blood 128, n.º 22 (2 de dezembro de 2016): 2478. http://dx.doi.org/10.1182/blood.v128.22.2478.2478.
Texto completo da fonteBrown, Ashley C., Riley H. Hannan, Lucas H. Timmins, Janet D. Fernandez, Thomas H. Barker e Nina A. Guzzetta. "Fibrin Network Changes in Neonates after Cardiopulmonary Bypass". Anesthesiology 124, n.º 5 (1 de maio de 2016): 1021–31. http://dx.doi.org/10.1097/aln.0000000000001058.
Texto completo da fonteGao, Chunli, Bin Bao, Chunling Bao e Wenhui Wu. "Fungi Fibrinolytic Compound 1 Plays a Core Role in Modulating Fibrinolysis, Altering Plasma Clot Structure, and Promoting Susceptibility to Lysis". Pharmaceutics 15, n.º 9 (14 de setembro de 2023): 2320. http://dx.doi.org/10.3390/pharmaceutics15092320.
Texto completo da fonteHantgan, Roy R., W. Gray Jerome e Marcie J. Hursting. "No Effect of Clot Age or Thrombolysis on Argatroban’s Inhibition of Thrombin". Blood 92, n.º 6 (15 de setembro de 1998): 2064–74. http://dx.doi.org/10.1182/blood.v92.6.2064.
Texto completo da fonteHantgan, Roy R., W. Gray Jerome e Marcie J. Hursting. "No Effect of Clot Age or Thrombolysis on Argatroban’s Inhibition of Thrombin". Blood 92, n.º 6 (15 de setembro de 1998): 2064–74. http://dx.doi.org/10.1182/blood.v92.6.2064.418k07_2064_2074.
Texto completo da fonteBaradet, T., J. W. Weisel e L. D. Peachey. "A study of fibrin clot structure under various ionic conditions using stereoscopic IVEM images". Proceedings, annual meeting, Electron Microscopy Society of America 49 (agosto de 1991): 194–95. http://dx.doi.org/10.1017/s0424820100085277.
Texto completo da fonteFlood, Veronica H., Chandrasekaran Nagaswami, Irina N. Chernysh, Hamid A. Al-Mondhiry, John W. Weisel e David H. Farrell. "Effects of Impaired Fibrinopeptide A Cleavage on Fibrin Clot Structure: Studies with an Aα R16C Dysfibrinogen." Blood 108, n.º 11 (16 de novembro de 2006): 1617. http://dx.doi.org/10.1182/blood.v108.11.1617.1617.
Texto completo da fonteJerome, W. Gray, Stefan Handt e Roy R. Hantgan. "Endothelial Cells Organize Fibrin Clots into Structures That Are More Resistant to Lysis". Microscopy and Microanalysis 11, n.º 3 (12 de maio de 2005): 268–77. http://dx.doi.org/10.1017/s143192760505052x.
Texto completo da fonteChernysh, Irina N., Prashant K. Purohit, Chandrasekaran Nagaswami e John W. Weisel. "Remodeling of Clots without Proteolytic Digestion". Blood 118, n.º 21 (18 de novembro de 2011): 1184. http://dx.doi.org/10.1182/blood.v118.21.1184.1184.
Texto completo da fonteGreenhalgh, Katie A., Mark W. Strachan, Saad Alzahrani, Paul D. Baxter, Kristina F. Standeven, Robert F. Storey, Robert A. S. Ariens, Peter J. Grant, Jackie F. Price e Ramzi A. Ajjan. "BβArg448Lys polymorphism is associated with altered fibrin clot structure and fibrinolysis in type 2 diabetes". Thrombosis and Haemostasis 117, n.º 02 (2017): 295–302. http://dx.doi.org/10.1160/th16-07-0554.
Texto completo da fonteKonings, Joke, José W. P. Govers-Riemslag, Helen Philippou, Nicola J. Mutch, Julian I. Borissoff, Peter Allan, Sumitra Mohan, Guido Tans, Hugo ten Cate e Robert A. S. Ariëns. "Factor XIIa regulates the structure of the fibrin clot independently of thrombin generation through direct interaction with fibrin". Blood 118, n.º 14 (6 de outubro de 2011): 3942–51. http://dx.doi.org/10.1182/blood-2011-03-339572.
Texto completo da fontede Vries, Judith J., Tamara Hoppenbrouwers, Cristina Martinez-Torres, Rezin Majied, Behiye Özcan, Mandy van Hoek, Frank W. G. Leebeek, Dingeman C. Rijken, Gijsje H. Koenderink e Moniek P. M. de Maat. "Effects of Diabetes Mellitus on Fibrin Clot Structure and Mechanics in a Model of Acute Neutrophil Extracellular Traps (NETs) Formation". International Journal of Molecular Sciences 21, n.º 19 (26 de setembro de 2020): 7107. http://dx.doi.org/10.3390/ijms21197107.
Texto completo da fonteDe Vries, Judith Juliana, Chantal Visser, Lotte Geers, Johan A. Slotman, Henrik Endeman, Marieke J. H. A. Kruip, Moniek P. M. de Maat e The Dutch COVID & Thrombosis Coalition. "Does Fibrin Structure Contribute to the Increased Risk of Thrombosis in COVID-19 ICU Patients?" Blood 138, Supplement 1 (5 de novembro de 2021): 3208. http://dx.doi.org/10.1182/blood-2021-145307.
Texto completo da fonteXu, Shixin, Zhiliang Xu, Oleg V. Kim, Rustem I. Litvinov, John W. Weisel e Mark Alber. "Model predictions of deformation, embolization and permeability of partially obstructive blood clots under variable shear flow". Journal of The Royal Society Interface 14, n.º 136 (novembro de 2017): 20170441. http://dx.doi.org/10.1098/rsif.2017.0441.
Texto completo da fonteNeergaard-Petersen, Søs, Anne-Mette Hvas, Steen Kristensen, Erik Grove, Sanne Larsen, Fladia Phoenix, Zeyad Kurdee, Peter Grant e Ramzi Ajjan. "The influence of type 2 diabetes on fibrin clot properties in patients with coronary artery disease". Thrombosis and Haemostasis 112, n.º 12 (2014): 1142–50. http://dx.doi.org/10.1160/th14-05-0468.
Texto completo da fonteJen, C. J., e L. V. McIntire. "Platelet Microtubules in Clot Structure Formation and Contractile Force Generation: Investigation of a Controversy". Thrombosis and Haemostasis 56, n.º 01 (1986): 023–27. http://dx.doi.org/10.1055/s-0038-1661596.
Texto completo da fonteLeong, Lilley, Irina N. Chernysh, Yifan Xu, Cornell Mallari, Billy Wong, Derek Sim, Adam Cuker et al. "Hemophilia a Clots Generated with Recombinant Factor VIIa Differed in Structure and Composition from Those Formed with Factor VIII". Blood 128, n.º 22 (2 de dezembro de 2016): 3798. http://dx.doi.org/10.1182/blood.v128.22.3798.3798.
Texto completo da fonteTutwiler, Valerie, Alina D. Peshkova, Giang Le Minh, Sergei Zaitsev, Rustem I. Litvinov, Douglas B. Cines e John W. Weisel. "Fibrinolysis of Contracted Blood Clots Depends on Whether Plasminogen Activator Acts from inside or Outside". Blood 132, Supplement 1 (29 de novembro de 2018): 3773. http://dx.doi.org/10.1182/blood-2018-99-119659.
Texto completo da fonteWhyte, Claire S., Akriti Rastogi, Ellis Ferguson, Michela Donnarumma e Nicola J. Mutch. "The Efficacy of Fibrinogen Concentrates in Relation to Cryoprecipitate in Restoring Clot Integrity and Stability against Lysis". International Journal of Molecular Sciences 23, n.º 6 (9 de março de 2022): 2944. http://dx.doi.org/10.3390/ijms23062944.
Texto completo da fonteUndas, Anetta, Krystyna Zawilska, Mariola Ciesla-Dul, Agata Lehmann-Kopydłowska, Agnieszka Skubiszak, Katarzyna Ciepłuch e Wiesława Tracz. "Altered fibrin clot structure/function in patients with idiopathic venous thromboembolism and in their relatives". Blood 114, n.º 19 (5 de novembro de 2009): 4272–78. http://dx.doi.org/10.1182/blood-2009-05-222380.
Texto completo da fonteSidelmann, Johannes, Mikkel Brabrand, Robert Pedersen, Jørgen Pedersen, Kim Esbensen, Kristina Standeven, Robert Ariëns, Jørgen Gram e Jonas Sjøland. "Fibrin clot structure in patients with end-stage renal disease". Thrombosis and Haemostasis 98, n.º 08 (2007): 339–45. http://dx.doi.org/10.1160/th06-12-0715.
Texto completo da fonteDavies, Nia Anne, Nicholas Kim Harrison, Roger H. Keith Morris, Simon Noble, Matthew James Lawrence, Lindsay Antonio D’Silva, Laura Broome et al. "Fractal dimension (df ) as a new structural biomarker of clot microstructure in different stages of lung cancer". Thrombosis and Haemostasis 114, n.º 12 (2015): 1251–59. http://dx.doi.org/10.1160/th15-04-0357.
Texto completo da fontede Vries, Judith J., Charlotte J. M. Snoek, Dingeman C. Rijken e Moniek P. M. de Maat. "Effects of Post-Translational Modifications of Fibrinogen on Clot Formation, Clot Structure, and Fibrinolysis". Arteriosclerosis, Thrombosis, and Vascular Biology 40, n.º 3 (março de 2020): 554–69. http://dx.doi.org/10.1161/atvbaha.119.313626.
Texto completo da fonteGaule, Thembaninkosi G., e Ramzi A. Ajjan. "Fibrin(ogen) as a Therapeutic Target: Opportunities and Challenges". International Journal of Molecular Sciences 22, n.º 13 (28 de junho de 2021): 6916. http://dx.doi.org/10.3390/ijms22136916.
Texto completo da fonteWeisel, John W. "Multiple Approaches to Visualizing Fibrin Clot Structure and Assembly". Microscopy and Microanalysis 3, S2 (agosto de 1997): 329–30. http://dx.doi.org/10.1017/s1431927600008539.
Texto completo da fonteGantioqui, Jorell, Ivan Stevic, Paul Y. Kim, Keith K. Lau, Anthony K. C. Chan e Howard H. W. Chan. "The Architecture Of Fibrin Clots Formed From Plasma With Low Platelet Levels Are Less Altered In The Presence Of Factor-Specific Anticoagulants Compared With Unfractionated Heparin". Blood 122, n.º 21 (15 de novembro de 2013): 578. http://dx.doi.org/10.1182/blood.v122.21.578.578.
Texto completo da fonteFaes, Camille, Anton Ilich, Amandine Sotiaux, Erica M. Sparkenbaugh, Michael W. Henderson, Laura Buczek, Joan D. Beckman et al. "Red blood cells modulate structure and dynamics of venous clot formation in sickle cell disease". Blood 133, n.º 23 (6 de junho de 2019): 2529–41. http://dx.doi.org/10.1182/blood.2019000424.
Texto completo da fonteVarin, Remi, Shahsultan Mirshahi, Pehzman Mirshahi, Jean Chidiac, Gerald Kierzek, Jean-Pierre Marie, Massoud Mirshahi, Claudine Soria e Jeannette Soria. "Effect of Rivaroxaban, An Oral Direct Factor Xa Inhibitor, On Whole Blood Clot Permeation and Thrombolysis: Critical Role of Red Blood Cells." Blood 114, n.º 22 (20 de novembro de 2009): 1064. http://dx.doi.org/10.1182/blood.v114.22.1064.1064.
Texto completo da fonteUndas, Anetta. "Fibrin clot properties and their modulation in thrombotic disorders". Thrombosis and Haemostasis 112, n.º 07 (2014): 32–42. http://dx.doi.org/10.1160/th14-01-0032.
Texto completo da fonteDargaud, Yesim, Jean C. Bordet, Chantal Huchon e Claude Negrier. "How can We Predict Efficacy of rFVIIa in Hemophilia Patients with Inhibitors?" Blood 114, n.º 22 (20 de novembro de 2009): 3487. http://dx.doi.org/10.1182/blood.v114.22.3487.3487.
Texto completo da fonteWeisel, John W., Tatiana Lebedeva, Chandrasekaran Nagaswami, Vincent M. Hayes, Walter Massefski, Rustem I. Litvinov, Lubica Rauova, Thomas J. Lowery e Douglas B. Cines. "Polyhedrocytes: Compressed Polyhedral Erythrocytes In Contracted Blood Clots and Thrombi". Blood 122, n.º 21 (15 de novembro de 2013): 452. http://dx.doi.org/10.1182/blood.v122.21.452.452.
Texto completo da fonteAjjan, Ramzi, Bernard C. B. Lim, Kristina F. Standeven, Robert Harrand, Sarah Dolling, Fladia Phoenix, Richard Greaves et al. "Common variation in the C-terminal region of the fibrinogen β-chain: effects on fibrin structure, fibrinolysis and clot rigidity". Blood 111, n.º 2 (15 de janeiro de 2008): 643–50. http://dx.doi.org/10.1182/blood-2007-05-091231.
Texto completo da fonteLandi, Elia, Marco Mugnaini, Tunahan Vatansever, Ada Fort, Valerio Vignoli, Elvira Giurranna, Flavia Rita Argento et al. "Advancing Thrombosis Research: A Novel Device for Measuring Clot Permeability". Sensors 24, n.º 12 (9 de junho de 2024): 3764. http://dx.doi.org/10.3390/s24123764.
Texto completo da fonteZąbczyk, Michał, Joanna Natorska e Anetta Undas. "Factor XIII and Fibrin Clot Properties in Acute Venous Thromboembolism". International Journal of Molecular Sciences 22, n.º 4 (5 de fevereiro de 2021): 1607. http://dx.doi.org/10.3390/ijms22041607.
Texto completo da fonteBowley, Sheryl R., e Susan T. Lord. "Fibrinogen variant BβD432A has normal polymerization but does not bind knob “B”". Blood 113, n.º 18 (30 de abril de 2009): 4425–30. http://dx.doi.org/10.1182/blood-2008-09-178178.
Texto completo da fontePan, Xiaoxi, Yun Gong, Ya Xu, Robert Ariens e Michael Routledge. "Urban Particulate Matter Induces Changes in Gene Expression in Vascular Endothelial Cells that Are Associated with Altered Clot Structure In Vitro". Thrombosis and Haemostasis 118, n.º 02 (2018): 266–78. http://dx.doi.org/10.1160/th17-05-0362.
Texto completo da fonteMoiseiwitsch, Nina, Kimberly A. Nellenbach, Nina A. Guzzetta, Ashley C. Brown e Laura Downey. "Ex Vivo and In Vivo Evaluation of Fibrinogen Concentrate to Mitigate Post-Surgical Bleeding in Neonates". Blood 138, Supplement 1 (5 de novembro de 2021): 1034. http://dx.doi.org/10.1182/blood-2021-153823.
Texto completo da fonteCollet, Jean-Philippe, Jennifer L. Moen, Yuri I. Veklich, Oleg V. Gorkun, Susan T. Lord, Gilles Montalescot e John W. Weisel. "The αC domains of fibrinogen affect the structure of the fibrin clot, its physical properties, and its susceptibility to fibrinolysis". Blood 106, n.º 12 (1 de dezembro de 2005): 3824–30. http://dx.doi.org/10.1182/blood-2005-05-2150.
Texto completo da fonte